Joost van der Hoek
-
- Pituitary Gland Disorders and Treatments 12
- Growth Hormone and Insulin-like Growth Factors 5
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 11
- Gastroenterology top 10%
- Neurology top 10%
- Neuroblastoma Research and Treatments 3
- Myasthenia Gravis and Thymoma 1
- Surgery top 10%
-
- Cancer, Hypoxia, and Metabolism 2
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Leo J. HoflandSteven W. J. LambertsRichard A. FeeldersWouter W. de HerderGisbert WeckbeckerPeter M. van KoetsveldDiana Sprij-MooijMarlijn Waaijers
- Journals
- The Journal of Clinical Endocrinology & Metabolism (2 papers)Journal of Medicinal Chemistry (1 paper)Clinical Chemistry (1 paper)
- Partner nations
- NetherlandsSwitzerlandBelgium
In The Last Decade
Joost van der Hoek
16 papers receiving 961 citations
Peers
Comparison fields: 5 of 64
- Endocrinology, Diabetes and Metabolism 714
- Epidemiology 416
- Gastroenterology 65
- Neurology 134
- Surgery 329
Countries citing papers authored by Joost van der Hoek
This map shows the geographic impact of Joost van der Hoek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joost van der Hoek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joost van der Hoek more than expected).
Fields of papers citing papers by Joost van der Hoek
This network shows the impact of papers produced by Joost van der Hoek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joost van der Hoek. The network helps show where Joost van der Hoek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joost van der Hoek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 9 | |
| 2 | 2010 | 160 | |
| 3 | 2009 | 18 | |
| 4 | 2007 | 20 | |
| 5 | 2005 | 127 | |
| 6 | 2005 | 225 | |
| 7 | 2005 | 21 | |
| 8 | 2005 | 46 | |
| 9 | 2005 | 9 | |
| 10 | 2005 | 2 | |
| 11 | 2004 | 161 | |
| 12 | 2004 | 117 | |
| 13 | 2004 | 36 | |
| 14 | 2004 | 5 | |
| 15 | The novel somatostatin analog SOM230 has a broad spectrum of inhibitory action on hormone release by human somatotroph, corticotroph and PRL-secreting pituitary adenomas in vitro | 2003 | 2 |
| 16 | New insights on SOM230, a universal somatostatin receptor ligand. | 2003 | 30 |
About Joost van der Hoek
Joost van der Hoek is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Neurology, having authored 16 papers that have together received 988 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (12 papers), Neuroendocrine Tumor Research Advances (11 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Neuroblastoma Research and Treatments (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Myasthenia Gravis and Thymoma (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (714 citations), Epidemiology (416 citations) and Gastroenterology (65 citations). Joost van der Hoek has collaborated with scholars based in Netherlands, Switzerland and Belgium. Frequent co-authors include Leo J. Hofland, Steven W. J. Lamberts, Richard A. Feelders, Wouter W. de Herder, Gisbert Weckbecker, Peter M. van Koetsveld, Diana Sprij-Mooij, Marlijn Waaijers, Christian Bruns and Albert Beckers. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Medicinal Chemistry and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.